Cargando…

Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer

The tumor microenvironment (TME) plays critical roles in immune modulation and tumor malignancies in the process of cancer development. Immune cells constitute a significant component of the TME and influence the migration and metastasis of tumor cells. Recently, a number of therapeutic approaches t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Wei, Li, Meiye, Luo, Kewang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384189/ https://www.ncbi.nlm.nih.gov/pubmed/37513975 http://dx.doi.org/10.3390/pharmaceutics15071788

Ejemplares similares

VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
por: Zhao, Yueshui, et al.
Publicado: (2022)

The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer
por: Luo, Lumeng, et al.
Publicado: (2021)

Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment
por: Abascal, Jensen, et al.
Publicado: (2023)

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer
por: Su, Dan, et al.
Publicado: (2021)

Therapeutic Targeting of Cancer-Associated Fibroblasts in the Non-Small Cell Lung Cancer Tumor Microenvironment
por: Shintani, Yasushi, et al.
Publicado: (2023)

Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer
por: Han, Rui, et al.
Publicado: (2023)

Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
por: Wang, Yuchang, et al.
Publicado: (2022)

Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence
por: Peng, Haoxin, et al.
Publicado: (2021)

Tumor Immune Microenvironment and Immunotherapy in Non-Small Cell Lung Cancer: Update and New Challenges
por: Xing, Shuqin, et al.
Publicado: (2022)

Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer
por: Li, Hui, et al.
Publicado: (2022)

Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles
por: Yoon, Hyun Jung, et al.
Publicado: (2020)

New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis
por: Shinohara, Shuichi, et al.
Publicado: (2022)

Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer
por: Duan, Jin, et al.
Publicado: (2022)

LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer
por: Pan, Hongyu, et al.
Publicado: (2020)

Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments
por: Chen, Shanshan, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma
por: Zhou, Pu, et al.
Publicado: (2021)

Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
por: Lin, Anqi, et al.
Publicado: (2019)

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer
por: Wu, Fengying, et al.
Publicado: (2021)

Pyroptosis-Related Gene Model Predicts Prognosis and Immune Microenvironment for Non-Small-Cell Lung Cancer
por: Luo, Lianxiang, et al.
Publicado: (2022)

Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer
por: Mao, Wenjun, et al.
Publicado: (2022)

COX-2-related tumor immune microenvironment in non-small cell lung cancer: a novel signature to predict hot and cold tumor
por: Wang, Tiangong, et al.
Publicado: (2022)

The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
por: Sun, Yueqin, et al.
Publicado: (2021)

The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery
por: Öjlert, Åsa Kristina, et al.
Publicado: (2019)

Immune microenvironment composition in non‐small cell lung cancer and its association with survival
por: Tamminga, Menno, et al.
Publicado: (2020)

Effects of pirfenidone targeting the tumor microenvironment and tumor-stroma interaction as a novel treatment for non-small cell lung cancer
por: Fujiwara, Ayako, et al.
Publicado: (2020)

Taraxasterol Inhibits Tumor Growth by Inducing Apoptosis and Modulating the Tumor Microenvironment in Non-Small Cell Lung Cancer
por: Lu, Junjie, et al.
Publicado: (2022)

NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer
por: Bai, Rui, et al.
Publicado: (2021)

Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer
por: Alifano, Marco, et al.
Publicado: (2014)

Prognostic value of RILPL2 and its correlation with tumor immune microenvironment and glycolysis in non-small cell lung cancer
por: Chen, Dongfang, et al.
Publicado: (2022)

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer
por: Zhou, Xiaohan, et al.
Publicado: (2023)

Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)
por: Li, Meichen, et al.
Publicado: (2022)

Targeted therapies in non-small cell lung cancer
por: Kyle, Fiona, et al.
Publicado: (2008)

Monoacylglycerol lipase deficiency in the tumor microenvironment slows tumor growth in non-small cell lung cancer
por: Kienzl, Melanie, et al.
Publicado: (2021)

Tumor immunity landscape in non-small cell lung cancer
por: Yu, Xiaoqing, et al.
Publicado: (2018)

Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2021)

m(6)A regulators featured by tumor immune microenvironment landscapes and correlated with immunotherapy in non-small cell lung cancer (NSCLC)
por: Yuan, Baowen, et al.
Publicado: (2022)

Circadian rhythm-associated clinical relevance and Tumor Microenvironment of Non-small Cell Lung Cancer
por: Li, Ming, et al.
Publicado: (2021)

ZNF143 Expression is Associated with COPD and Tumor Microenvironment in Non-Small Cell Lung Cancer
por: Feng, Zhenxing, et al.
Publicado: (2022)

EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
por: Madeddu, Clelia, et al.
Publicado: (2022)

NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer: Retraction
por: Bai, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0c1s4fpd4n1uecbss9fn2mf4lm